Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 115303
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.115303
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.115303
Table 2 Comparison of preoperative spectral computed tomography parameters between two groups, mean ± SD
| Parameter | Non-complication group | Complication group | Statistic | P value |
| Arterial phase parameters | ||||
| Tumor iodine concentration (μg/cm³) | 18.7 ± 6.8 | 13.4 ± 5.9 | t = 5.487 | < 0.001 |
| Normal bowel wall iodine concentration (μg/cm³) | 12.3 ± 4.2 | 11.8 ± 4.5 | t = 0.787 | 0.432 |
| Abdominal aorta iodine concentration (μg/cm³) | 210.4 ± 45.7 | 208.9 ± 48.2 | t = 0.214 | 0.831 |
| Erector spinae iodine concentration (μg/cm³) | 11.2 ± 3.8 | 10.8 ± 4.1 | t = 0.731 | 0.465 |
| Tumor normalized iodine concentration | 0.089 ± 0.025 | 0.064 ± 0.022 | t = 7.015 | < 0.001 |
| Tumor effective atomic number | 8.21 ± 0.47 | 7.86 ± 0.52 | t = 4.729 | < 0.001 |
| Tumor λHU | 2.84 ± 0.68 | 2.31 ± 0.59 | t = 5.425 | < 0.001 |
| Tumor plain CT value (HU) | 34.5 ± 8.7 | 35.1 ± 9.2 | t = -0.443 | 0.658 |
| Tumor CT value (HU) | 67.8 ± 18.9 | 54.2 ± 16.7 | t = 5.053 | < 0.001 |
| Abdominal aorta CT value (HU) | 268.4 ± 52.3 | 265.7 ± 48.9 | t = 0.363 | 0.717 |
| Erector spinae CT value (HU) | 40.8 ± 12.4 | 40.1 ± 13.7 | t = 0.350 | 0.726 |
| Tumor 40 keV CT value (HU) | 142.7 ± 38.4 | 115.3 ± 32.1 | t = 5.030 | < 0.001 |
| Tumor enhancement degree (HU) | 33.3 ± 15.2 | 19.1 ± 12.8 | t = 6.625 | < 0.001 |
| Tumor relative enhancement rate (%) | 98.7 ± 47.3 | 56.2 ± 39.1 | t = 6.352 | < 0.001 |
| Portal venous phase parameters | ||||
| Tumor iodine concentration (μg/cm³) | 22.9 ± 7.3 | 16.8 ± 6.4 | t = 5.879 | < 0.001 |
| Normal bowel wall iodine concentration (μg/cm³) | 15.7 ± 5.1 | 15.2 ± 5.4 | t = 0.639 | 0.524 |
| Abdominal aorta iodine concentration (μg/cm³) | 158.3 ± 32.1 | 155.9 ± 35.4 | t = 0.480 | 0.632 |
| Erector spinae iodine concentration (μg/cm³) | 10.4 ± 3.2 | 9.9 ± 3.6 | t = 1.000 | 0.318 |
| Tumor normalized iodine concentration | 0.145 ± 0.031 | 0.108 ± 0.027 | t = 8.406 | < 0.001 |
| Tumor effective atomic number | 8.45 ± 0.52 | 8.07 ± 0.58 | t = 4.659 | < 0.001 |
| Tumor λHU | 3.12 ± 0.74 | 2.58 ± 0.67 | t = 5.109 | < 0.001 |
| Tumor CT value (HU) | 89.4 ± 22.1 | 71.6 ± 19.8 | t = 5.690 | < 0.001 |
| Abdominal aorta CT value (HU) | 184.7 ± 38.9 | 181.2 ± 41.3 | t = 0.580 | 0.563 |
| Erector spinae CT value (HU) | 40.5 ± 12.1 | 39.8 ± 13.2 | t = 0.369 | 0.712 |
| Tumor 40 keV CT value (HU) | 178.3 ± 45.7 | 142.9 ± 38.9 | t = 5.498 | < 0.001 |
| Tumor enhancement degree (HU) | 54.9 ± 18.4 | 36.5 ± 15.7 | t = 7.105 | < 0.001 |
| Tumor relative enhancement rate (%) | 161.8 ± 58.2 | 106.3 ± 48.9 | t = 6.781 | < 0.001 |
| Derived parameters | ||||
| Iodine concentration difference (μg/cm³) | 4.2 ± 2.8 | 3.4 ± 2.1 | t = 2.152 | 0.032 |
| Arterial phase tumor-muscle iodine concentration ratio | 1.68 ± 0.42 | 1.34 ± 0.38 | t = 5.642 | < 0.001 |
| Portal venous phase tumor-muscle iodine concentration ratio | 2.21 ± 0.56 | 1.79 ± 0.47 | t = 5.339 | < 0.001 |
| Arterial phase tumor-muscle CT value ratio | 1.67 ± 0.38 | 1.36 ± 0.34 | t = 5.718 | < 0.001 |
| Portal venous phase tumor-muscle CT value ratio | 2.22 ± 0.51 | 1.83 ± 0.43 | t = 5.376 | < 0.001 |
- Citation: Duan R, Li HL, Deng L, Zhao Q, Yang RW, Wu ZL. Preoperative spectral computed tomography multi-parameter prediction of postoperative complications in colorectal cancer: A single-center retrospective cohort study. World J Gastrointest Oncol 2026; 18(5): 115303
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/115303.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.115303